IA
VYGR icon

IndexIQ Advisors’s Voyager Therapeutics VYGR Stock Holding History

IndexIQ Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-89,662
Closed -$243K – 1534
2021
Q4 		$243K Sell
89,662
-5,794
-6% -$19.8K 0.01% 1003
2021
Q3 		$251K Buy
95,456
+9,561
+11% +$31.1K 0.01% 1014
2021
Q2 		$355K Buy
85,895
+2,278
+3% +$10.3K 0.01% 890
2021
Q1 		$394K Buy
+83,617
New +$570K 0.01% 872

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IndexIQ Advisors's VYGR Position: Q1 2022 in Review

IndexIQ Advisors sold out of Voyager Therapeutics (VYGR) in Q1 2022, closing a stake of 89,662 shares — an estimated $243K sold.

IndexIQ Advisors first reported a position in VYGR in Q1 2021 and held it in 4 quarters. The position peaked at $394K in Q1 2021. 70 funds tracked by Wall St. Rank hold VYGR as of Q1 2022.

  • IndexIQ Advisors reported no remaining Voyager Therapeutics position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 89,662 Voyager Therapeutics shares in Q1 2022, an estimated $243K.
  • IndexIQ Advisors first reported a position in Voyager Therapeutics in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Voyager Therapeutics position peaked at $394K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.